Professor Moon Jin-soo as Public Vice President of Seoul National University Hospital and Professor Kim Dong-wan as Vice President of Cancer Care
Mar 14, 2025
Seoul National University Hospital announced that it appointed Professor Moon Jin-soo of the Department of Pediatrics as the public vice president and Professor Kim Dong-wan of Hematologic Oncology as the cancer treatment vice president. The terms of the two professors are two years from March 15, 2025 to March 14, 2027.
Moon Jin-soo, the new vice president of public affairs, served as a professor of pediatric and adolescent departments at Seoul National University Hospital and served as a director of pediatric medical support and a professor in charge of pediatric policy development. In particular, Professor Moon led the establishment of health checkups and physical development standards for infants and toddlers, and had a great influence on the development of public health policies in Korea.
He is currently serving as the joint research project manager of the pediatric cancer and rare disease support project group at Seoul National University Hospital, the director of the Unification Medical Center at Seoul National University, the chairman of the planning and policy committee of the Korean Pediatric Youth Association, and the next president of the Korean Pediatric Gastroenterology Association. Professor Moon plans to further develop the public sector of Seoul National University Hospital by leading various projects to strengthen public medical services and develop policies.
Kim Dong-wan, the new head of the cancer treatment department, served as a professor of hematologic oncology at Seoul National University Hospital and served as the head of the clinical trial center, the head of the oncology center, the head of the cancer treatment department, and the head of the QA center. Professor Kim is an expert in the field of lung cancer anticancer drug treatment and has led a number of innovative new drug clinical trials to achieve many achievements in patient-specific treatment. In the future, Professor Kim plans to continue to maintain Seoul National University Cancer Hospital's position as a world-leading institution in cancer research and treatment and to provide patient-centered care.
Meanwhile, Park Joong-shin, head of the Medical Department, Choi Eun-hwa, head of the Pediatric Medical Department, Kim Yong-jin, head of the Medical Life Research Institute, Song Jeong-han, head of Bundang Seoul National University Hospital, Lee Jae-hyeop, head of the Seoul Boramae Hospital, Cho Young-min, head of the Planning and Coordination Office, Kang Hyun-jae, head of the Education Human Resources Development Office, Lee Jae-young, head of the Medical Innovation Office, Park Do-joong, head of the External Cooperation Office, and Jeong Chang-wook, head of the Information Society Office, were reappointed.
Moon Jin-soo, the new vice president of public affairs, served as a professor of pediatric and adolescent departments at Seoul National University Hospital and served as a director of pediatric medical support and a professor in charge of pediatric policy development. In particular, Professor Moon led the establishment of health checkups and physical development standards for infants and toddlers, and had a great influence on the development of public health policies in Korea.
He is currently serving as the joint research project manager of the pediatric cancer and rare disease support project group at Seoul National University Hospital, the director of the Unification Medical Center at Seoul National University, the chairman of the planning and policy committee of the Korean Pediatric Youth Association, and the next president of the Korean Pediatric Gastroenterology Association. Professor Moon plans to further develop the public sector of Seoul National University Hospital by leading various projects to strengthen public medical services and develop policies.
Kim Dong-wan, the new head of the cancer treatment department, served as a professor of hematologic oncology at Seoul National University Hospital and served as the head of the clinical trial center, the head of the oncology center, the head of the cancer treatment department, and the head of the QA center. Professor Kim is an expert in the field of lung cancer anticancer drug treatment and has led a number of innovative new drug clinical trials to achieve many achievements in patient-specific treatment. In the future, Professor Kim plans to continue to maintain Seoul National University Cancer Hospital's position as a world-leading institution in cancer research and treatment and to provide patient-centered care.
Meanwhile, Park Joong-shin, head of the Medical Department, Choi Eun-hwa, head of the Pediatric Medical Department, Kim Yong-jin, head of the Medical Life Research Institute, Song Jeong-han, head of Bundang Seoul National University Hospital, Lee Jae-hyeop, head of the Seoul Boramae Hospital, Cho Young-min, head of the Planning and Coordination Office, Kang Hyun-jae, head of the Education Human Resources Development Office, Lee Jae-young, head of the Medical Innovation Office, Park Do-joong, head of the External Cooperation Office, and Jeong Chang-wook, head of the Information Society Office, were reappointed.
|
This article was translated by Naver AI translator.
